Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry.
Rojas JI, Patrucco L, Trojano M, Lugaresi A, Izquierdo G, Butzkueven H, Jokubaitis V, Duquette P, Girard M, Grand'Maison F, Grammond P, Oreja-Guevara C, Hupperts R, Boz C, Petersen T, Bergamaschi R, Giuliani G, Lechner-Scott J, Barnett M, Rio ME, Van Pesch V, Amato MP, Iuliano G, Fiol M, Slee M, Verheul F, Fernandez-Bolanos R, Poehlau D, Saladino ML, Braber-Moerland LD, Deri N, Oleschko-Arruda W, Cabrera-Gomez JA, Paine M, Vella N, Kister I, Skromne E, Savino A, Shaw C, Moore F, Vucic S, Petkovska-Boskova T, Bacile EAB, Santiago V, Cristiano E. Rojas JI, et al. Among authors: trojano m. Mult Scler J Exp Transl Clin. 2015 Aug 17;1:2055217315600193. doi: 10.1177/2055217315600193. eCollection 2015 Jan-Dec. Mult Scler J Exp Transl Clin. 2015. PMID: 28607702 Free PMC article.
European validation of a standardized clinical description of multiple sclerosis.
Amato MP, Grimaud J, Achiti I, Bartolozzi ML, Adeleine P, Hartung HP, Kappos L, Thompson A, Trojano M, Vukusic S, Confavreux C; Evaluation of the EDMUS system (EVALUED) Study Group. Amato MP, et al. Among authors: trojano m. J Neurol. 2004 Dec;251(12):1472-80. doi: 10.1007/s00415-004-0567-0. J Neurol. 2004. PMID: 15645346
Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.
Bergamaschi R, Quaglini S, Trojano M, Amato MP, Tavazzi E, Paolicelli D, Zipoli V, Romani A, Fuiani A, Portaccio E, Berzuini C, Montomoli C, Bastianello S, Cosi V. Bergamaschi R, et al. Among authors: trojano m. J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):757-9. doi: 10.1136/jnnp.2006.107052. Epub 2007 Jan 12. J Neurol Neurosurg Psychiatry. 2007. PMID: 17220286 Free PMC article.
Subcutaneous Interferon Beta-1a Has a Positive Effect on Cognitive Performance in Mildly Disabled Patients with Relapsing-Remitting Multiple Sclerosis: 2-Year Results from the COGIMUS Study.
Patti F, Amato MP, Bastianello S, Caniatti L, Di Monte E, Lijoi F, Goretti B, Messina S, Picconi O, Tola MR, Trojano M. Patti F, et al. Among authors: trojano m. Ther Adv Neurol Disord. 2009 Mar;2(2):67-77. doi: 10.1177/1756285608101379. Ther Adv Neurol Disord. 2009. PMID: 21180642 Free PMC article.
Anxiety and depression in multiple sclerosis patients around diagnosis.
Giordano A, Granella F, Lugaresi A, Martinelli V, Trojano M, Confalonieri P, Radice D, Solari A; SIMS-Trial group. Giordano A, et al. Among authors: trojano m. J Neurol Sci. 2011 Aug 15;307(1-2):86-91. doi: 10.1016/j.jns.2011.05.008. Epub 2011 May 31. J Neurol Sci. 2011. PMID: 21621796 Clinical Trial.
Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Picconi O, Cilia S, Cottone S, Grimaldi LM; COGIMUS study group. Patti F, et al. Among authors: trojano m. Qual Life Res. 2012 Sep;21(7):1111-21. doi: 10.1007/s11136-011-0021-6. Epub 2011 Sep 28. Qual Life Res. 2012. PMID: 21953022
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study.
Bastianello S, Giugni E, Amato MP, Tola MR, Trojano M, Galletti S, Luccichenti G, Quarantelli M, Picconi O, Patti F; COGIMUS study group. Bastianello S, et al. Among authors: trojano m. BMC Neurol. 2011 Oct 14;11:125. doi: 10.1186/1471-2377-11-125. BMC Neurol. 2011. PMID: 21999142 Free PMC article. Clinical Trial.
467 results